Literature DB >> 19554505

Vaspin and amylin are expressed in human and rat placenta and regulated by nutritional status.

Jorge E Caminos1, Susana B Bravo, Maria F Garcés, C Ruth González, Libia A Cepeda, Adriana C González, Rubén Nogueiras, Rosalía Gallego, Tomás García-Caballero, Fernando Cordido, Miguel López, Carlos Diéguez.   

Abstract

Amylin (islet amyloid polypeptide) and vaspin (visceral adipose tissue specific serpin) are gut and adipocyte hormones involved in the regulation of body weight homeostasis. The aim of this study was to examine whether amylin and vaspin are expressed in human and rat placenta, as well as their regulation by nutritional status. Our results demonstrate that amylin and vaspin are localized in both human and rat placenta. In the rat term placenta vaspin was demonstrated in the trophoblast of the fetal villi, the labyrinth. Vaspin immunostaining in human placenta was localized in cytotrophoblast and syncytiotrophoblast in the first trimester placentas while in the third trimester vaspin was localized in the syncytiotrophoblast. Regarding amylin, rat placenta of 16 days of gestational age showed an intense immunostaining, mainly localized in the labyrinth. On the other hand, in the human third trimester placenta amylin immunoreactivity was intense in the syncytiotrophoblast of the chorionic villi and in decidual cells. Furthermore, placental amylin and vaspin showed an opposite pattern of expression during pregnancy, with vaspin showing the highest expression level at the end and amylin at the beginning of pregnancy. Finally, food restriction also has contrary effects on their expression, increasing vaspin but decreasing amylin placental mRNA and protein levels. Taken together, our results demonstrate that vaspin and amylin are modulated by energy status in the placenta, which suggests that these proteins may be involved in the regulation of placental metabolic functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19554505     DOI: 10.14670/HH-24.979

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

Review 1.  Role of Cholesterol and Phospholipids in Amylin Misfolding, Aggregation and Etiology of Islet Amyloidosis.

Authors:  Sanghamitra Singh; Saurabh Trikha; Diti Chatterjee Bhowmick; Anjali A Sarkar; Aleksandar M Jeremic
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

2.  Plasma levels and placental expression of vaspin in pregnant women with diabetes mellitus.

Authors:  Y Huo; S X Liu; G Y Song; L P Ren; C Wang; D H Zhang
Journal:  Braz J Med Biol Res       Date:  2015-01-20       Impact factor: 2.590

3.  Involvement of Amylin and Leptin in the Development of Projections from the Area Postrema to the Nucleus of the Solitary Tract.

Authors:  Kathrin Abegg; Andreas Hermann; Christina N Boyle; Sebastien G Bouret; Thomas A Lutz; Thomas Riediger
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-28       Impact factor: 5.555

Review 4.  Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus.

Authors:  Monika Ruszała; Magdalena Niebrzydowska; Aleksandra Pilszyk; Żaneta Kimber-Trojnar; Marcin Trojnar; Bożena Leszczyńska-Gorzelak
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 5.  Adipokines as drug targets in diabetes and underlying disturbances.

Authors:  Vinícius Andrade-Oliveira; Niels O S Câmara; Pedro M Moraes-Vieira
Journal:  J Diabetes Res       Date:  2015-04-08       Impact factor: 4.011

Review 6.  New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides.

Authors:  Ewa Mlyczyńska; Marta Kieżun; Patrycja Kurowska; Monika Dawid; Karolina Pich; Natalia Respekta; Mathilde Daudon; Edyta Rytelewska; Kamil Dobrzyń; Barbara Kamińska; Tadeusz Kamiński; Nina Smolińska; Joelle Dupont; Agnieszka Rak
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.